US equities |
NVDA $238.90 ▲+2.12% SPCX $171.09 ▲+7.63% MU $1,063.96 ▼-1.02% TSLA $378.73 ▲+2.20% WBD $30.95 ▲+0.03% MSFT $525.18 ▲+1.48% AAPL $332.89 ▼-0.24% SNDK $1,704.16 ▼-0.92%
FinancialContent

ProShares Ultra Russell2000 (NY:UWM)

58.91 +0.78 (+1.34%)
Official Closing Price Updated: 4:10 PM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ProShares Ultra Russell2000

News headline image
T1 Energy Dives 12% As Culper Research Takes A Short Position Saying Company Is A ‘Failed EV Battery SPAC’ ↗
Culper Research said it has little faith in T1’s management, nor the company’s disclosures and financial reporting and said that shares are headed far lower. 
Via Stocktwits
Topics Lawsuit
FLYX Stock Surged Over 130% Today — What’s The SpaceX Connection? ↗
Via Stocktwits
Rumble Rallies After Unveiling Tether-Powered Crypto Wallet – Retail Expects Stock To Surpass The $10 Mark ↗
Via Stocktwits
Zeta Global Shares Rose After It Deepens Collaboration with OpenAI ↗
Via Stocktwits
News headline image
Tonix Pharmaceuticals To Meet With FDA In 2026 To Advance Experimental Lyme Disease Prevention Drug ↗
The company also announced the pricing of a $20 million registered direct offering. 
Via Stocktwits
News headline image
Why Is UUUU Stock Rising Today? ↗
The company said that its finished uranium production, mined uranium ore production, and uranium concentrate sales for FY 2025 exceeded previously announced guidance. 
Via Stocktwits
Topics Government World Trade
BlackSky Technology Is The Latest Space Stock To Grab Investor Attention — Jefferies Expects Sales To Double In A Few Years ↗
Via Stocktwits
Why Did Outset Medical Stock Tumble Today? ↗
Via Stocktwits
TG Therapeutics Stock Soars After Company Ups Guidance For Multiple Sclerosis Drug ↗
Via Stocktwits
News headline image
Compass Diversified Stock Plunges On ‘Most Significant Loss’ After Fraud Forces Removal Of Three Years Of Financials ↗
The company has removed financial information for the years 2022 to 2024 from its website, citing non-reliance. 
Via Stocktwits
Topics Fraud
Akebia Therapeutics Stock Slumps After FDA Meeting Ends Without Path Forward for Vafseo Label Expansion ↗
Via Stocktwits
News headline image
BBIO Stock Soars After Experimental Drug Shows Improvement In Inherited Muscle Disorder In Late-stage Trial ↗
BridgeBio now intends to file a new drug application for the therapy's approval in the first half of 2026. 
Via Stocktwits
News headline image
Why Did Tvardi Therapeutics Stock Plummet 87% Pre-Market Today? ↗
The company said that its investigational drug did not meet its goal in a study, and no statistically significant differences between placebo and treatment arms were observed after preliminary review... 
Via Stocktwits
Cidara Therapeutics Granted FDA Breakthrough Therapy Designation For Flu-Preventing Antiviral ↗
Via Stocktwits
Lexeo Therapeutics Stock Rallies On Discussions With FDA To Expedite Friedreich’s Ataxia Drug Approval Process ↗
Via Stocktwits
AnaptysBio Stock Gets A Price Target Hike After Announcing Plan To Separate Royalty, Biopharma Businesses – Check Out The New Level ↗
Via Stocktwits
Wolfpack Research Reveals Short Position In EV Maker Faraday Future ↗
Via Stocktwits
Krispy Kreme Stock Pops After FBI Director Kash Patel Reportedly Endorses It As A ‘Good Investment’: Retail Chatter Soars Over 600% ↗
Via Stocktwits
Rapport Therapeutics Stock Rockets 204% Pre-Market To Head Toward All-Time Highs – Here’s What Happened ↗
Via Stocktwits
This Pharma Stock Shot Up 4% Pre-Market After FDA Approval For Drug, Retail’s Super Bullish But Believes ‘This Is A Marathon, Not A Sprint’ ↗
Via Stocktwits
News headline image
“A” Significant Low Is In For Stocks – “THE” Bottom Likely 4-8 Weeks Off ↗
When we left off on Wednesday morning which seemed like a year ago, I showed a number of charts that were supportive of the stock market finding “A” bottom earlier this week. 
Via Talk Markets
Topics Stocks / Equities
News headline image
7 Dividend Stocks to Avoid as Interest Rates Rise in 2023 ↗
Until it becomes clear that the Fed is gearing up to pivot on rate hikes, avoid these seven worst dividend stocks for rising rates. 
Via InvestorPlace
News headline image
United Mortgage Stops Accepting Bitcoin, Ethereum, Dogecoin Payments After Just 6 Weeks ↗
Six weeks after it launched a program to accept payments in cryptocurrency, United Wholesale Mortgage (NYSE: 
Via Benzinga
News headline image
PreMarket Prep Recap: The 4 Stocks Dennis Dick Bought Yesterday ↗
On Wednesday’s PreMarket Prep, co-hosts Joel Elconin and Dennis Dick discussed the bullish chart setups in several tech stocks. ... 
Via Benzinga